90 related articles for article (PubMed ID: 122404)
21. Anterior pituitary function in Cushing's syndrome: study of 36 patients.
Cuerda C; Estrada J; Marazuela M; Vicente A; Astigarraga B; Bernabeu I; Diez S; Salto L
Endocrinol Jpn; 1991 Oct; 38(5):559-63. PubMed ID: 1843276
[TBL] [Abstract][Full Text] [Related]
22. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
[TBL] [Abstract][Full Text] [Related]
23. Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease.
Boccuzzi G; Angeli A; Bisbocci D; Fonzo D; Giadano GP; Ceresa F
J Clin Endocrinol Metab; 1975 May; 40(5):892-5. PubMed ID: 1092712
[TBL] [Abstract][Full Text] [Related]
24. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
25. Cushing's disease: management by transsphenoidal pituitary microsurgery.
Bigos ST; Somma M; Rasio E; Eastman RC; Lanthier A; Johnston HH; Hardy J
J Clin Endocrinol Metab; 1980 Feb; 50(2):348-54. PubMed ID: 7354119
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.
Shimizu C; Yamane Y; Ishizuka T; Kijima H; Takano K; Takano A; Kubo M; Koike T
Endocr J; 2001 Jun; 48(3):303-9. PubMed ID: 11523900
[TBL] [Abstract][Full Text] [Related]
27. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
28. Predicting relapse after transsphenoidal surgery for Cushing's disease.
Toms GC; McCarthy MI; Niven MJ; Orteu CH; King TT; Monson JP
J Clin Endocrinol Metab; 1993 Feb; 76(2):291-4. PubMed ID: 8432771
[TBL] [Abstract][Full Text] [Related]
29. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
30. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
31. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients.
Cohen R; Bouquier D; Biot-Laporte S; Vermeulen E; Claustrat B; Cherpin MH; Cabrera P; Guidetti P; Ferry S; Bizollon CA
J Clin Endocrinol Metab; 1986 May; 62(5):892-8. PubMed ID: 3007559
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease.
Pieters GF; Hermus AR; Meijer E; Smals AG; Kloppenborg PW
J Clin Endocrinol Metab; 1989 Dec; 69(6):1122-6. PubMed ID: 2555381
[TBL] [Abstract][Full Text] [Related]
33. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
34. Does an analysis of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal surgery in Cushing's disease?
Buchfelder M; Fahlbusch R; Wentzlaff-Eggebert H; Brabant G; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1993 Sep; 77(3):720-4. PubMed ID: 8396575
[TBL] [Abstract][Full Text] [Related]
35. Isolated deficiency of adrenocorticotropin (ACTH) and lipotropins (LPHs).
Nichols ML; Brown RD; Granville GE; Cunningham GR; Tanaka K; Orth DN
J Clin Endocrinol Metab; 1978 Jul; 47(1):84-90. PubMed ID: 233663
[TBL] [Abstract][Full Text] [Related]
36. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.
Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407
[TBL] [Abstract][Full Text] [Related]
37. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
38. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
[TBL] [Abstract][Full Text] [Related]
39. [Pituitary microadenoma of Cushing's disease. Course following transsphenoidal excision. Four cases (author's transl)].
Guibout M; Jaquet P; Grisoli F; Louvet JP; Combes R; Angeletti S; Mouly A
Nouv Presse Med; 1979 Oct; 8(37):2959-63. PubMed ID: 503829
[TBL] [Abstract][Full Text] [Related]
40. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
